Value in the bio-economy is better theorized through assetization than commodification.

Evidence

First, this configuration consists of legal rights and obligations, such as property rights to knowledge (i.e., IPRs; Zeller 2008; Pistor 2013), as well as organizational and managerial practices (e.g., corporate governance, accounting) that enable the monetizing and capitalizing of knowledge through specific organizational entities (e.g., biotech firm; Mirowski 2012). As a result, it is just as (if not more?) important to theorize value in the bio-economy in terms of financialization, capitalization, and assetization as it is to theorize it in terms of concepts more commonly found in the STS literature on value, such as commodification, liveliness, surplus vitality, and suchlike. — Kean Birch, Rethinking Value in the Bio-economy, 112

Categorization

• XREF: Connects directly to the foundational assetization debate in finance/STS scholarship (Birch, Muniesa, Pistor on valuation as social practice). — connects to: Analyzing bio-economy value requires focusing on assets rather than commodities — Kean Birch, Rethinking Value in the Bio-economy:…, 68; Value in the bio-economy is managed through asset governance, not product sales. — Kean Birch, Rethinking Value in the Bio-economy:…, 88; In the bioeconomy, informational signaling about assets, not product sales, constitutes firm value. — Kean Birch, Rethinking Value in the Bio-economy:…, 106 (+2 more)
• ADDENDUM: The core conceptual framing of assetization versus commodification could anchor a follow-up piece extending the grafting/infrastructure pieces’ treatment of how living systems become economically productive.

Related

• Analyzing bio-economy value requires focusing on assets rather than commodities (similarity 0.94)
• Understanding value requires studying the assets underpinning firm valuation, not commodity production. (similarity 0.92)
• Value in the bio-economy is managed through asset governance, not product sales. (similarity 0.92)
• Bio-economy valuation practices are not peculiar to that sector. (similarity 0.90)
• Asset value is constituted by active management within organizations, not by biological properties. (similarity 0.88)
• Value in the bio-economy is produced through valuation practices, not intrinsic to biological matter. (similarity 0.88)
• In the bioeconomy, informational signaling about assets, not product sales, constitutes firm value. (similarity 0.88)
• Understanding value as assetization requires analyzing political economy, not just applying STS to finance. (similarity 0.85)
• Asset value derives from future earnings rather than intrinsic commodity value (similarity 0.85)
• Value is not inherent in things but achieved through capitalization practices. (similarity 0.85)
• Capitalization scholarship often treats capital as a living thing embodied in commodities. (similarity 0.84)
• Accounting for biological assets reflects chosen methods, not intrinsic biological qualities (similarity 0.84)
• Capitalization builds the thing being valued at the same time it appraises that thing (similarity 0.83)
• Value is constituted by knowledge and practice, not merely hype. (similarity 0.82)
• Asset value is actively managed, including downward, and its constructedness is obscured. (similarity 0.81)

Broader Connections

• Bio-economy valuation practices are not peculiar to that sector. #qualifies (0.75) — Kean Birch, Rethinking Value in the Bio-economy, 121
• Assetization constitutes a distinct logic of investment irreducible to speculation or rentiership #expands (0.72) — Paul Langley, Assets and Assetization in…, 27